WH Shorts Hold Steady as Stock Leads the Lodging Pack
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
WH edged ahead of its closest peers this week, gaining 5.4% to close at $77.35 against a median weekly gain of roughly 4.9% across the lodging group.
CHH led the pack with a 9.2% weekly rise, and HLT added 9.0%, both outpacing WH slightly on the week. IHG and TNL gained 6.9% and 6.6% respectively. WH's move was still strong in absolute terms, and the month tells a more impressive story: shares are up 13.6% over the past 30 days, suggesting WH has been catching up rather than leading all along. The question the positioning data raises is whether that catch-up has come with shorts trimming or simply sitting still.
Short interest has barely moved over the week, down less than half a percent to 10.1% of free float, roughly 7.6 million shares. The month is a different story: short positions grew by around 10.8% over the past 30 days, most of that jump arriving around October 9 to 12, when shares on loan climbed from roughly 6.8 million to 7.7 million in two sessions and stayed there. That positioning has not unwound despite the subsequent rally, which means a portion of the short book is sitting on losses relative to where it was built. Borrow conditions remain entirely unthreatening: cost to borrow fell 18% on the week to 0.38%, and availability is at 2,693%, well above even the 52-week low of 208%. There is no scarcity of borrow, no squeeze mechanics at play, and no sign that existing shorts are being forced to cover on anything other than their own conviction.
Options positioning has quietly turned less defensive than it looked a month ago. The put/call ratio has drifted down to 1.67, now about one standard deviation below its 20-day average of 1.84. That average itself is still elevated by historical standards, with the 52-week range spanning 0.20 to 2.32, but the direction of travel is toward fewer puts being added relative to calls. The most dramatic options shift happened around September 15 to 18, when the PCR collapsed from above 2.0 to 0.20, suggesting a large options restructuring at that point. Since then the ratio has settled into a steady downward drift, consistent with the improving price performance.
The Street is constructive on the name. Morgan Stanley raised its target to $92 from $91 on October 12 while keeping its Overweight rating, a small but directionally positive move from a bellwether firm. Freedom Broker initiated at Buy with an $88 target on October 14. The consensus price target stands at $96.56, implying roughly 25% upside from current levels. Most of the negative analyst activity came earlier this summer, when JPMorgan, Barclays, Susquehanna, and Truist all trimmed targets after Q2 results disappointed on RevPAR. None changed their positive ratings, but the target cuts reflect lingering scepticism about the demand environment. The analyst recommendation factor scores at the 92nd percentile of the universe, an unusually high reading that reflects the breadth of buy-side support even after those target reductions. Forward EPS momentum scores in the 73rd percentile on a 12-month basis, though near-term momentum is softer, sitting in the low 40s. The stock's short score has eased to 52.5 from 53.6 a week ago, consistent with slightly less short pressure.
The CEO, Geoffrey Ballotti, sold approximately $1.4 million in shares on October 15 under a pre-arranged 10b5-1 plan. The same plan also triggered option exercises at $65.21. The 10b5-1 designation makes these mechanical rather than discretionary, and net insider activity over 90 days shows roughly $2.8 million in net sales, a modest number for a $5.6 billion market cap company. No 13D activist filer is on the register. BlackRock holds 10.0% as the largest institutional owner, and T. Rowe Price holds 5.3%, both reported as of September 30. Norges Bank trimmed its position by 344,000 shares as of June 30, and Capital Research cut from roughly 10.3% to 3.2% disclosed in February, a significant reduction that predates the current positioning picture but is worth noting as context for why the institutional register looks lighter than it once did.
The next earnings release is October 22. The most recent comparable print, in July, saw the stock fall 2.8% on the day before recovering to close the five-day window roughly flat. The level to watch is whether short interest, which has been stable near 10.1% since early October, begins to move after the report, either covering into a positive reaction or rebuilding if the guidance on RevPAR and EBITDA disappoints again.
Stocks in this article
See the live data behind this article on ORTEX.
Open WH on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 22:39
- Data as of
- 21 Oct 2026, 22:38
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.